<?xml version="1.0"?>
<trials subjects="1">
  <Triall>
    <main>
      <UTRN />
      <trial_id>ChiCTR-INR-16008399</trial_id>
      <utrn />
      <reg_name>ChiCTR</reg_name>
      <date_registration>2016-05-01</date_registration>
      <primary_sponsor>The first affiliated hospital of Xi'an jiaotong university</primary_sponsor>
      <public_title>Cotransplantation of haploidentical peripheral blood stem cells and mesenchymal stem cells for acute leukemia: a randomized, controlled clinical study</public_title>
      <acronym />
      <scientific_title>Cotransplantation of haploidentical peripheral blood stem cells and mesenchymal stem cells for acute leukemia: a randomized, controlled clinical study</scientific_title>
      <Scientific_acronym />
      <date_enrolment>2016-05-03</date_enrolment>
      <type_enrolment />
      <target_size>experimental group A:12;experimental group B:12;control group:12;</target_size>
      <recruitment_status>Recruiting</recruitment_status>
      <url>http://www.chictr.org.cn/showproj.aspx?proj=14141</url>
      <study_type>Interventional study</study_type>
      <study_design>Randomized parallel controlled trial</study_design>
      <phase>New Treatment Measure Clinical Study</phase>
      <hc_freetext>acute leukemia</hc_freetext>
      <i_freetext>experimental group A:cotransplantation of haploidentical peripheral blood stem cells and mesenchymal stem cells (d0);experimental group B:cotransplantation of haploidentical peripheral blood stem cells and mesenchymal stem cells (d+30);control group:haploidentical peripheral blood stem cell transplantation;</i_freetext>
      <results_actual_enrolment />
      <results_date_completed />
      <results_url_link />
      <results_summary />
      <results_date_posted />
      <results_date_first_publication />
      <results_baseline_char />
      <results_participant_flow />
      <results_adverse_events />
      <results_outcome_measures />
      <results_url_protocol />
      <results_IPD_plan />
      <results_IPD_description />
    </main>
    <contacts>
      <contact>
        <type>Scientific</type>
        <firstname>WANG XIAONING</firstname>
        <middlename />
        <lastname />
        <address>277 West Yanta Road, Xi'an, Shaanxi, China</address>
        <city />
        <country1 />
        <zip>710061</zip>
        <telephone>+86 18991232608</telephone>
        <email>wangxn99@163.com</email>
        <affiliation>The first affiliated hospital of Xi'an jiaotong university</affiliation>
      </contact>
      <contact>
        <type>Public</type>
        <firstname>HE PENGCHENG</firstname>
        <middlename />
        <lastname />
        <address>277 West Yanta Road, Yanta District, Xi'an, China</address>
        <city />
        <country1 />
        <zip>710061</zip>
        <telephone>+86 18991232609</telephone>
        <email>hepc@163.com</email>
        <affiliation>The first affiliated hospital of Xi'an jiaotong university</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>China</country2>
    </countries>
    <criteria>
      <inclusion_criteria>1. Acute leukemia patients (including AML and ANML) at first complete remission before transplantation;
2. HLA matching of the donor and the patients was haploidentical;
3. Patients recieved allogeneic hematopoietic stem cell transplantation in our hospital from January 2016 to   
December 2019.</inclusion_criteria>
      <agemin>14</agemin>
      <agemax>55</agemax>
      <gender>Both</gender>
      <exclusion_criteria>1. Patients aged 14~55 years old;
2. Patients don't achieve remission;
3. Patients with heart,lung or kidney dysfunction;
4. Patients with mental disorders;
5. Pregnancy patients with leukemia.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code />
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword />
    </health_condition_keyword>
    <intervention_code>
      <i_code>;;;</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword />
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>overall survival;rate of relapse;</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>rate of graft;rate of aGVHD and cGVHD;</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name />
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id />
        <issuing_authority />
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Clinical research project of the First Affiliated Hospital of Xi'an Jiao Tong University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2016-01-28</approval_date>
        <contact_name />
        <contact_address />
        <contact_phone />
        <contact_email />
      </ethics_review>
    </ethics_reviews>
  </Triall>
</trials>